Relmada Therapeutics (OTCMKTS:RLMD) Stock Price Down 0.3%

Share on StockTwits

Relmada Therapeutics Inc (OTCMKTS:RLMD)’s stock price fell 0.3% on Wednesday . The stock traded as low as $1.79 and last traded at $1.80, 13,162 shares changed hands during trading. A decline of 48% from the average session volume of 25,307 shares. The stock had previously closed at $1.80.

Separately, ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st.

The company’s fifty day moving average is $2.29.

Relmada Therapeutics (OTCMKTS:RLMD) last posted its earnings results on Tuesday, May 14th. The company reported ($0.09) earnings per share for the quarter.

In other news, Director Paul Edward Kelly bought 100,000 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was purchased at an average cost of $1.50 per share, with a total value of $150,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 6.10% of the stock is owned by insiders.

About Relmada Therapeutics (OTCMKTS:RLMD)

Relmada Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic pain, and/or other potential CNS pathological conditions.

See Also: Stock Symbols and CUSIP Explained

Receive News & Ratings for Relmada Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relmada Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Piedmont Lithium  vs. Its Peers Financial Analysis
Piedmont Lithium vs. Its Peers Financial Analysis
Head-To-Head Analysis: Marriott International  versus Wyndham Hotels & Resorts
Head-To-Head Analysis: Marriott International versus Wyndham Hotels & Resorts
Qutoutiao  and FactSet Research Systems  Financial Review
Qutoutiao and FactSet Research Systems Financial Review
Reviewing Cogent Communications  and Blackbaud
Reviewing Cogent Communications and Blackbaud
Critical Comparison: Home Bancorp  versus Hingham Institution for Savings
Critical Comparison: Home Bancorp versus Hingham Institution for Savings
Critical Contrast: Hailiang Education Group  & National American University Holdngs
Critical Contrast: Hailiang Education Group & National American University Holdngs


© 2006-2019 Ticker Report